Multiple "halo nevi" occurring during pembrolizumab treatment for metastatic melanoma

Int J Dermatol. 2019 Jun;58(6):739-741. doi: 10.1111/ijd.14239. Epub 2018 Sep 19.

Authors

Irène Nicolétis-Lombart¹, Thibault Kervarrec², Julia Zaragoza¹, Marie Christine Machet², Mahtab Samimi¹

Affiliations

¹ Dermatology, CHU Tours, Tours, France.
² Anatomical pathology, CHU Tours, Tours, France.

PMID: 30229873
DOI: 10.1111/ijd.14239

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / adverse effects*
Antineoplastic Agents, Immunological / adverse effects*
Chemotherapy, Adjuvant / adverse effects
Chemotherapy, Adjuvant / methods
Female
Humans
Lymph Node Excision
Lymphatic Metastasis
Melanoma / secondary
Melanoma / therapy*
Neoplasm Recurrence, Local / drug therapy
Neoplasm Recurrence, Local / pathology
Nevus, Halo / chemically induced*
Nevus, Halo / immunology
Nevus, Halo / pathology
Skin / drug effects
Skin / immunology
Skin / pathology
Skin Neoplasms / pathology
Skin Neoplasms / therapy*

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
pembrolizumab